| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |